Introduction and motivation

The Italian proverb cited above is a fitting motto for Orio’s life—he was always willing to consider a new idea. When, at a European Group of Insurance Economists (EGRIE) meeting, a paper of mine drew criticism, he would say, “At least this piece encourages us to think outside the box”. As the former manager of a jazz radio station in Trieste (Italy), he arranged for bass and drums to accompany Jim Garven (Baylor University) on the flute and myself on the piano at a short gig at the EGRIE seminar of 1987 in Geneva. That was ‘outside the box’ too because he had never heard either of us play before.

Orio’s heart lay with the more applied contributions that, today, would be published in the Issues & Practice series of The Geneva Papers. For this reason, this paper is motivated by a practical issue that concerned this author 10 years ago. At the conference, ‘Insuring the Health of an Ageing Population’ organised by The Geneva Association, the delegate of a U.K. pension insurer described an interesting innovation, which has become known as an enhanced annuity. When the company learns of a serious health condition, it offers the policyholder an extra payment to finance some of the expenditure that is not covered by health insurance. This is feasible because the condition lowers the insured’s remaining life expectancy and hence reduces the number of years the annuity has to be paid. When this innovation was reported by this author in the newspaper Neue Zürcher Zeitung (NZZ), no fewer than three managers representing different divisions of the same (!) insurer called, keen to know details. At a quickly arranged meeting, they committed to reaching a decision within three months as to whether their company would launch a similar innovation. Well, as stated above, this was 10 years ago, and the company is still deciding…

Admittedly, launching an innovation in insurance is not easy. It is more than risky. It is uncertain because crucial probabilities are not sufficiently known:

  • The new product may attract unfavourable risks, aggravating the adverse selection problem. In the example cited above, the condition causing the reduction in remaining life expectancy might be negatively correlated with other health conditions, which counteract the shortening of life expectancy. However, if all we know is that the coefficient of correlation is less than 0.5 (say), the information is too weak to be of value in conventional approaches.

  • In non-life insurance, very high losses are too rare to enable estimation of their probability of occurrence with a sufficient degree of precision. This means that reserves allocated to that particular line are insufficient with a probability of at least 5% (say); again, very weak information.

  • Sometimes, a block of policies can be acquired from another company. The issue then arises as to whether these policies increase overall risk exposure or help diversify risk. The information available suggests that risk diversification is more probable than increased risk exposure; this is not sufficient to reach a well-founded decision.

  • For the bottom line, the rate of return that can be achieved on capital investment is crucial. Forward guidance by the Federal Reserve and the European Central Bank may be lacking, as these institutions do not firmly commit to a future policy. However, they may indicate that a continuation of their zero interest rate policy is not very likely (say); once again, weak information.

All these instances are subject to at least partial uncertainty in the sense of Knight (1921), who first distinguished between risk and uncertainty. In the case of risk, probabilities are known; in the case of complete uncertainty, they are unknown. However, in many cases relevant for insurance, experience and research yield at least some information, which arguably can and should be exploited for decision-making.

In the case of true uncertainty, one is thrown back to following Wald (1945), who viewed nature as an adversary to human decision-makers. In this situation, only the pessimistic maximin decision rule appropriate for zero-sum games can be applied. If at least the intervals in which the payoffs (i.e. the outcomes expressed in money units) lie are known with certainty, the Hurwicz criterion (Hurwicz 1951) is recommended. It proposes using a linear combination of the maximin and the maximax values, with the weight of the maximax value (the highest of all possible maxima) reflecting the decision-maker’s degree of optimism.Footnote 1 The downside of this alternative is that the optimism parameter is purely subjective.

Rather than discussing additional decision-making criteria [see Gilboa (2013), in particular chapters 7 and 15–17 for a survey], this contribution presents the theory of linear partial information (LPI) as a way to bridge the gap between uncertainty and risk. LPI theory, pioneered by Kofler and Menges (1977), can deal with any linear information about probabilities and payoffs (imprecise intervals can be expressed in terms of restrictions on probabilities) and does not require any subjective weighting parameter. The price to be paid is the assumption that the decision-maker is engaged in a game against nature. Since her survival is assured, nature need not be fully adversarial by always choosing the outcome that inflicts maximum loss on the decision-maker. Nature is adversarial to the extent that she presents the decision-maker with the urn containing the probability distribution with the minimum expected payoff. Accordingly, the LPI decision rule is the maxEmin criterion, a natural relaxation of Wald’s maximin criterion.

Kofler and Menges (1977) were able to show that a piece of information regarding probabilities of possible outcomes such as r1 ≥ r3 (with r1 + r2 + r3 + ··· rn = 1) can be systematically exploited for decision-making. LPI theory has led to a series of publications, notably by Kofler and Menges (1979), Kofler (1988) and Kofler and Zweifel (1988, 1991, 1993).

LPI theory is just one alternative for dealing with what is commonly called ambiguity. A natural idea is to define probabilities over probabilities, e.g. over r1, such as Prob(r1 = 0.9) = 0.1, Prob(r1 = 0.8) = 0.1, Prob(r1 = 0.7) = 0.2, Prob(r1 = 0.6) = 0.3, etc. The resulting unambiguous probability distribution, e.g. r1 = 0.7, r2 = 0.3, could then be used to calculate the insurer’s expected profit. However, actual decision-makers were soon found to evaluate the original compound lottery in a different way from the reduced one (Bar-Hillel 1973). This finding led to an extended literature on the axioms necessary to preserve the equivalence between the two settings and the importance of ambiguity aversion in the event these axioms are not satisfied. An elegant solution was proposed by Klibanoff et al. (2005), who introduce two transformations. One is the well-known risk utility function, which reflects the probabilities, the other, a transformation defined over these probabilities, reflects the decision maker’s ambiguity aversion. Yet, as the authors’ (Klibanoff et al. 2012) lengthy reply to a critique by Epstein (2010) shows, the construction of the convolution of these two transformations is anything but straightforward. As will become evident in the next section, LPI theory offers a much simpler, practical alternative.

Applying LPI theory to a decision-making situation at an innovating insurance company

In this contribution, LPI theory is applied to the decision-making situation of an insurance company that considers launching a new product such as the pension plan with payment adjusted for changes in remaining life expectancy described in the previous section (see Fig. 2 below for the pertinent decision tree).

Calculating the minimum expected payoff if the innovation is launched

As always, the decision tree is solved backwards, starting with its upper branch where the insurance company (IC for short) launches the innovation. At the market level, let r1 = probability of a favourable reception of the innovation, r2 = probability of a neutral reception, and r3 = probability of an unfavourable reception. If the regulatory authority R approves and competitor C abstains from launching its own innovation, then let the respective payoffs be USD million {100, 50, 10} in present value terms.Footnote 2 These figures are realistic in view of the fact that the annual premium incomes of major insurers are in USD tens of billions (Statista 2019).

As to the probabilities, let the only available information be r1 ≥ r3, which precludes calculation of an expected payoff value using traditional approaches. However, LPI can be used to calculate the so-called maxEmin value as a guide for decision-makers, as will be shown below.

The first step is to identify the relevant probability distributions. In the left-hand panel of Fig. 1, each point on the triangular plane defined by r1 + r2 + r3 = 1 reflects a distribution. The shaded triangular plane represents those distributions which satisfy the restriction, r1 ≥ r3. In the right-hand panel, the same plane is shown as a triangle confined by the vertices ABD. Evidently, all points contained in the triangular area ABD represent distributions that satisfy r1 ≥ r3.Footnote 3 Note that this set is still infinite. However, it can be reduced to a finite number of elements at the price of the following assumption. The decision-maker is engaged in a game against nature, which is zero-sum in expected values, calling for application of the maxEmin decision rule.

Fig. 1
figure 1

The set of relevant probability distributions in three-dimensional and two-dimensional space

The maxEmin criterion is an intuitive generalisation of the pessimistic maximin criterion, where the decision-maker assumes that nature (or an adversary more generally) always chooses the action which has minimum payoff to him or her. Applying Wald’s (1945) maximin criterion ensures the decision-maker’s survival in a fully hostile environment. However, nature, acting as one’s adversary, will always survive so has no need to consistently opt for the action inflicting the greatest possible loss to the human decision-maker. Rather, she can afford to confront him or her with the probability distribution giving rise to the minimum expected payoff. Among these relevant distributions, the decision-maker can opt for the one that guarantees the maximum payoff on expectation through his or her choice of action. This amounts to applying the maxEmin criterion.

Applying the maxEmin criterion has a crucial benefit. Since nature can be assumed to be risk neutral, her preferences are in terms of expected values, which are linear functions of probabilities. This makes her indifference curves linear, as shown by the dashed lines on the right-hand side of Fig. 1. However, she cannot reach point C with the distribution (0,0,1) in view of the LPI: r1 ≥ r3. Her optimum cannot be in the interior of ABD either but must lie at one of its vertices ABD.Footnote 4 This follows from the fundamental equivalence between a zero-sum game and a linear programme (Chiang 1984, Sect. 21.4). The optimum solution to a linear programme is given by one of the extreme points of the feasible region (Chiang 1984, Theorem II in Sect. 18.3). These extreme points (vertices) satisfy the condition that for a k-dimensional feasible space, the number of restrictions satisfied as exact equalities is also k (Chiang 1984, Sect. 18.4; also see fn. 3).

In the present context, n = 3; therefore, it is sufficient to consider the vertices A, B and D, where the restrictions r1 ≥ r3 and r1 + r2 + r3 = 1 are satisfied as equalities. The vertices characterising the relevant probabilities at the market level can be assembled in the matrix \(V\left[ M \right]\):

$$\begin{aligned} V\left[ M \right] = \left[ \begin{array} {lll} 1 &\quad 0&\quad 1/2 \hfill \\ 0&\quad 1 &\quad 0 \hfill \\ 0&\quad 0 &\quad 1/2 \hfill \\ \end{array} \right] \\ {\text{ (A) }} \quad {\text{(B) }}\quad {\text{(D) }} \hfill \\ \end{aligned}$$
(1)

Hence, the relevant expected payoffs EP at node M1 of Fig. 2 are (minimum underscored)

$$EP\left[ {M_{1} } \right] = \left[ {100 \quad 50 \quad { 10}} \right]\left[ \begin{gathered} 1 \quad 0 \quad 1/2 \hfill \\ 0 \quad 1 \quad 0 \hfill \\ 0 \quad 0 \quad 1/2 \\ \end{gathered} \right] = \left[ {100 \quad \mathop {50}\limits_{ - - } \quad { 55}} \right]$$
(2)
Fig. 2
figure 2

Decision-making situation at the innovating insurance company

Given that nature is antagonistic, she will choose the distribution associated with the minimum expected payoff. The value of the game to the decision-maker (prior to deducting the outlay on product development) is therefore USD 50 million (entered at node M1 in Fig. 2).

However, C may launch a similar innovation of its own. In that event, a standard assumption is that the market is split in half between the two competitors as long as their products are not strongly differentiated, following Hotelling (1929) and Salop (1979). Therefore, payoffs to the IC are reduced to USD million {50, 25, 5}, giving rise to expected payoffs at node M2

$$EP\left[ {M_{2} } \right] = \left[ {{50 }\quad 25\quad { 5}} \right] \, \left[ \begin{gathered} {1\quad 0\quad 1/2} \hfill \\ {0\quad 1 \quad 0 } \hfill \\ {0 \quad 0 \quad 1/2 } \hfill \\ \end{gathered} \right] = \left[ {50 \quad \mathop {25}\limits_{ - - }\quad { 27}{\text{.5}}} \right]$$
(3)

with a minimum value of USD 25 million.

To calculate the minimum expected value of its payoff at node C1, the IC needs an estimate of the likelihood of C successfully launching an innovation of its own. This is strategic information that is not easy to come by. So, let the best estimate be at least 80% probability of C going ahead, implying sa < 0.2 for abstention. In the left panel of Fig. 3, the pertinent vertices C, B and D are shown in two-dimensional space; in the right panel, they appear in one-dimensional space. Therefore, the relevant vertices are given by

$$\begin{aligned} V\left[ M \right] = \left[ \begin{array}{ll} 0 &\quad 0.2 \hfill \\ 1& \quad 0.8\\ \end{array} \right] \\ (B) \quad (D)\end{aligned}$$
(4)
Fig. 3
figure 3

The set of relevant probability distributions at point C1 of Fig. 2, sa < 0.2

Therefore, one obtains the expected payoffs to the IC

$$EP\left[ {C_{1} } \right] = \left[ 50\quad 25 \right] \, \left[ \begin{gathered} {0\quad 0}{\text{.2}} \hfill \\ {1\quad 0}{\text{.8 }} \hfill \\ \end{gathered} \right] = \left[ {\mathop {25}\limits_{ - - }\quad \quad { 30}} \right]$$
(5)

with the minimum equal to USD 25 million. The qualification ‘successfully’ points to a shortcut in the analysis. In fact, C also needs to obtain approval by R, which is uncertain. However, in the spirit of the maxEmin principle, approval is taken as a given, constituting the worst-case scenario for the IC.

Up to this point, the regulatory authority R was assumed to approve the IC’s innovation. Even if C abstains from launching its own innovation, the IC will have no extra premium income if approval is denied. With payoffs equal to zero, the expected values of the game at node M3 are given by

$$EP\left[ {M_{3} } \right] = \left[ 0\quad 0 \quad 0 \right]$$
(6)

with the minimum equal to zero. However, C might come up with its own innovation; if C is of a similar size as the IC and obtains approval, it will garner the same payoffs in USD million {100, 50, 10} as the IC. According to the Hotelling–Salop rule, one half amounts to forgone premium income for the IC, which constitutes an opportunity cost to it. Using the same vertices as in Eq. (1), one thus obtains the expected payoffs to the IC at node M4

$$EP\left[ {M_{4} } \right] = \left[ { - {50 } - 25 \, - {5}} \right] \, \left[ \begin{gathered} {1\quad 0\quad \quad 1/2} \hfill \\ {0\quad 1\quad 0 } \hfill \\ {0\quad 0 \quad 1/2 } \hfill \\ \end{gathered} \right]=\left[ { - \mathop {50}\limits_{ - - } \quad - 25 \quad - {27}{\text{.5}}} \right]$$
(7)

with a minimum of USD − 50 million.

For calculating expected payoffs at node C2, where approval of its new product is denied, the IC needs to take into account that this failure will encourage competitor C to go ahead. Still, there may be considerations preventing C from proceeding, resulting in a probability of launch of less than one. Assuming that the probability of abstention \(s_{{\text{a}}}^{\prime }\) is less than 10% in this situation, one has the restrictions \(s_{{\text{a}}}^{\prime } < 0.1\) and \(s_{{\text{a}}}^{\prime } + s_{{\text{b}}}^{\prime } = 1.\) Therefore, the vertices at node C2 are, in analogy to Fig. 3,

$$V\left[ {C_{2} } \right] = \left[ \begin{gathered} {0\quad 0}{\text{.1 }} \hfill \\ {1\quad 0}{\text{.9 }} \hfill \\ \end{gathered} \right]$$
(8)

giving rise to relevant expected payoffs

$$EP\left[ {C_{2} } \right] = \left[ {0 \quad - 50} \right]\left[ \begin{gathered} {0\quad 0}{\text{.1 }} \hfill \\ {1\quad 0}{\text{.9 }} \hfill \\ \end{gathered} \right] = \left[ { - \mathop {50}\limits_{ - - } \quad - 45} \right]$$
(9)

and a minimum value of USD − 50 million at node C2.

Next, the IC has to gauge the likelihood of attaining approval by the regulatory authority R. An important consideration in the present context is that the IC needs information from a health insurer concerning the occurrence of the condition and its precise nature in order to estimate the reduction in remaining life expectancy. However, health insurance is at least as strictly regulated as pension insurance, making approval uncertain. For concreteness, let the perceived likelihood of approval be between 50% and 75%, respectively. With the pertinent vertices, one obtains expected payoff values at node r1

$$EP\left[ {R_{1} } \right] = \left[ {{25 } - 50} \right]\left[ \begin{gathered} {0}{\text{.5}}\quad {0.75 } \hfill \\ {0}{\text{.5}}\quad {0.25} \hfill \\ \end{gathered} \right] = \left[ { - \mathop {12.5}\limits_{ - - } \quad 6.25} \right]$$
(10)

Therefore, the minimum expected payoff pertaining to the upper branch of the decision tree in Fig. 2 (launch) amounts to USD − 12.5 million. It should be noted that this is an assured minimum payoff from the product innovation, but still in terms of expected value.

The lower branch of Fig. 2 is evaluated in the Appendix. The guaranteed expected payoff in the case that the innovation is not launched amounts to USD − 37.5 million.

Applying the maxEmin decision rule

Under the maxEmin decision rule introduced in the previous section, the optimal decision for the IC is unambiguous, in spite of the imprecise value of the probabilities involved. It makes sense to launch the innovation and to incur an expected negative payoff of USD − 12.5 million unless product development costs at least USD 25 million because not launching the innovation would be associated with an even greater loss of USD − 37.5 million. It is therefore preferable to launch the innovation.

Evidently, the same type of LPI procedure can be applied to the other problems confronting insurers cited in the Introduction.

Limitations and extensions of LPI theory

The most important limitation of LPI theory is the lack of evidence concerning application of the maxEmin decision rule. Other criteria that do not rely on knowledge of probabilities (contrary to expected utility theory) have been examined, at least experimentally. While Wald’s (1945) maximin rule does not seem to have been confronted with empirical evidence, the less pessimistic maximin regret rule has been at least partially confirmed by Zeelenberg and Pieters (2004) and Filiz-Ozbay and Ozbay (2007) in the context of auctions. There, the successful bidder often realises that he or she paid too much, motivating the minimisation of the maximum divergence between his or her decision and the truly optimal one (Niehans 1948; Savage 1951).

Another approach to partial information regarding probabilities and payoffs is ambiguity (Schmeidler 1989). The effect of ambiguity on decision-making has been confirmed experimentally by Kelsey and le Roux (2018) in the context of the so-called battle of the sexes, a two-person zero-sum game. Avoidance of ambiguity is shown to have positive value to the players. Arguably, this provides indirect support to LPI theory, which provides a measure of the value of information (and hence willingness to pay for the avoidance of ambiguity). To illustrate, let it be known that the probability of the IC obtaining regulatory approval is precisely 75% rather than between 50% and 75% (for simplicity, minimum expected payoffs are retained at M1 to M4 as well as C1 and C2). Then, the expected payoff at node r1 amounts to

$$EP^{\prime}\left[ {R_{1} } \right] = \left[ {{25 } - 50} \right]\left[ \begin{gathered} {0}{\text{.75 }} \hfill \\ 0.25 \hfill \\ \end{gathered} \right] = 6.25$$
(11)

Evidently, the removal of ambiguity would turn the innovation into a profitable investment in expected value terms. Under the maxEmin rule, the avoidance of ambiguity is worth USD 6.25 million [= 6.25 − (− 12.5)] on expectation.

As to extensions, LPI theory allows one to render all the elements of the decision tree of Fig. 2 uncertain or more uncertain. Starting with the payoffs, the figure 100 at the top can be replaced by e.g. {110, 90} with probabilities q1 and q2, where 2q1 < q2 (say). In Fig. 2, this would call for a set of additional nodes under the control of nature with vertices {[1/3, 2/3]′, [0, 1]′}. Of course, uncertainty with regard to the development cost of the new product can be introduced in the same way.

Next, there may be several sources of information characterised by their respective credibility, as in Kofler and Zweifel (1988). For instance, a market research firm might come up with the pessimistic prediction r1 < r3, indicating that an unfavourable market response is more likely than a favourable one. The management of the IC then needs to come up with a (usually rather subjective) estimate of the likelihood that this information, rather than the original, is true. Typically, this estimate will be in the guise of an LPI associated with still another set of nodes under the control of nature. The dynamic integration of new information can also be modelled as a Bayesian process resulting in an a priori and an a posteriori LPI, as in Kofler and Zweifel (1993).

In addition, there may be more than one competitor, each characterised by its own LPI regarding the probability of launching an innovation. This calls for the convolution of LPIs at node C1 in Fig. 2, as expounded in Kofler and Zweifel (1991). Finally, the IC may consider investing its funds in something else, giving rise to an entire decision tree of its own. This alternative will also typically be fraught with uncertainties, which can be modelled using LPI theory and calls for a whole set of convolutions.

Concluding remarks

This contribution is clearly ‘outside the box’ of risk theory and the economics of insurance but it might have pleased Orio Giarini. It proposes the analysis of LPI in a situation between uncertainty, defined as partial or complete ignorance of probabilities of occurrence, and risk, where probabilities are known to the decision-maker. The example used is that of an insurance company that considers launching an innovative product but cannot gauge precisely the likelihood of a favourable reception by the market, the probability of a competitor launching its own innovation or the chance of approval by the regulatory authority. Nevertheless, LPI theory provides ambiguous advice to the management of the company—provided they are prepared to accept the so-called maxEmin criterion in a game against nature. The assumption is that nature presents humans with the probability distribution entailing the maximum expected payoff to herself and hence the minimum payoff to the decision-maker. The decision-maker in turn opts for the action that maximises his or her expected payoff.

LPI theory can be extended to cover ambiguity with regard to payoffs to and costs of an innovation, integrating additional information of limited credibility, learning from it, ambiguity with regard to the number of competitors and their intentions, and investment in another possible project with uncertain prospects. The one element currently lacking is experimental evidence concerning the actual use of the maxEmin principle, comparing it to expected utility (profit, respectively), maximin regret and maximin decision rules. Hopefully this contribution will motivate future research in this direction!